JAK2 mutation detection (Primary myelofibrosis)


Description

V617F only. Qualitiative allelic discrimination with a sensitvity of approximately 10%


Request a test

When requesting this test please use the referral form provided. Please also refer to any additional information provided for this test. Download the referral form >


Additional information

Myeloproliferative Disorders (MPD) are clonal disorders of haematopoietic progenitors. The G1849T base substitution occurs in exon 14 of the tyrosine kinase JAK2 gene and results in the V617F mutation. The V617F mutation has been observed in up to 50-60% of patients with PMF


Sending address

Paediatric Malignancy Unit Great Ormond Street Hospital for Sick Children Level 2, Camelia Botnar Laboratories Great Ormond Street London WC1N 3JH

Laboratory service

Paediatric Malignancy Unit


Sample requirements

5 mls EDTA peripheral blood or bone marrow


Reference range

Not applicable


Turnaround time

7-10 working days


Disease / group

Primary myelofibrosis


Cost

Upon request


Call in advance?

Please call in advance to discuss requirements


Paediatric Malignancy Unit

The Paediatric Malignancy Unit is a unit providing a wide range of molecular genetic and cytogenetic diagnostic tests...

© 2011 Great Ormond Street Hospital for Children NHS Trust